Source: Annual Congress 2006 - Interstial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Kluge, P. Camus (Doetinchem, Netherlands; Dijon, France). Drug induced lung disease made handy and ready: the PDA version of Pneumotox ®. Eur Respir J 2006; 28: Suppl. 50, 4756

Member's Comments

No comment yet.

Related content which might interest you: Pneumotox – An updated time-saving web resource Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Patient's device preference in study of new inhaler. Do patients find the new device user-friendly? Source: International Congress 2014 – Medical education: web and internet Year: 2014 From Bench to edside: Development of a drug to treat lung disease from a basic research start Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Drug induced lung disease: 11 cases Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Development of image processing-based smartphone App (Application Software) for self-management of inhaled medicines for patients with asthma or COPD Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer Source: International Congress 2017 – Scientific year in review Year: 2017 Drug induced interstitial lung disease: a systematic review Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Management of stable COPD: Are GOLD recommendations fully applied? Source: Annual Congress 2010 - COPD: management Year: 2010 Computer bronchophonography is a new lung function diagnostic method in children Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 LSC - 2018 - In vivo models of Drug Induced ILD; tools to study and improve drug safety Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Electronic nose as a screening tool for early stage lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Lung TB: from easy to treat to nightmare Source: International Congress 2017 – CC1 Life-threatening mediastinitis and TB Year: 2017 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 COPD case-finding application: SYNERGY project Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes  Year: 2016 COPD-6 mini-spirometer: Feasible for early detection of COPD in general practice? Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016